Avalo Therapeutics Cash Flow Statement (2014-2025) | AVTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-0.11M	0.07M	0.08M	-0.07M					-9.96M	-8.19M	-5.23M	-8.17M	-121.29M	98.46M	23.04M	-35.34M	-13.15M	-20.77M	-30.62M	-13.72M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	1.45M	3.07M	1.76M	1.89M	5.31M	0.67M	0.73M	0.84M	0.85M	0.89M	0.95M	0.78M	0.63M	0.47M	1.85M	2.90M	3.24M	2.72M	3.15M	4.51M
Deferred Taxes (Quarter)	0.02M	0.01M	0.01M	-0.06M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	-0.01M	0.01M	0.01M	-0.01M	0.11M	0.01M	0.02M	0.01M	0.13M
Gains from Investment Securities (Quarter)			2.00M	-0.63M				1,700.00M					79.28M	-112.05M	-36.02M	-5.00M				-0.51M
Asset Writedowns and Impairment (Quarter)
Non-cash Items (Quarter)
Cash from Operations (Quarter)	-18.32M	-19.19M	-16.29M	-17.10M	-16.07M	-12.47M	5.73M	-3.94M	-10.05M	-11.03M	-6.84M	-2.77M	-6.20M	-16.28M	-11.53M	-15.04M	-9.50M	-11.35M	-16.36M	-14.29M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)		0.10M	0.34M	0.35M	0.35M	0.34M	0.35M	0.35M	0.35M	0.35M	0.90M								0.35M	0.20M
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	0.45M	0.46M	0.46M	0.29M	0.07M	0.03M	0.03M	0.04M	0.03M	0.04M	0.04M	0.04M	0.03M	0.03M	0.03M	0.07M	0.14M	0.13M	0.06M	0.02M
Change in Working Capital
Change in Receivables (Quarter)	-0.15M	2.10M	-1.67M	-1.39M	-2.29M	-0.14M	0.01M	0.60M	-1.06M	1.10M	-0.42M	-1.40M	-0.10M	0.10M	0.86M	-0.39M
Change in Inventory (Quarter)	-0.00M	0.02M	-0.00M	0.02M	-0.01M	-0.00M	-0.00M	-0.00M	-0.00M	-0.00M	-0.02M
Change in Account Payables (Quarter)	9.34M	-9.66M	1.32M	-0.20M	0.39M	-1.59M	-0.72M	1.44M	2.68M	-4.81M	0.04M	-0.34M	0.47M	-0.26M	1.16M	-1.53M	0.40M	1.69M	-1.89M	-0.34M
Change in Accured Expenses (Quarter)	1.72M	3.19M	-2.31M	0.65M	-2.29M	-1.25M	0.39M	-0.49M	-4.94M	-0.69M	-2.46M	-0.96M	-1.65M	0.40M	-0.86M	1.00M	-1.70M	1.99M	1.02M	5.35M
Change in Taxes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	0.02M		0.08M	0.01M			0.10M		0.16M
Sales of Property, Plant and Equipment (Quarter)									0.03M
Acquisitions (Quarter)													0.36M
Divestments (Quarter)
Change in Acquisitions & Divestments (Quarter)																				21.50M
Cash from Investing Activities (Quarter)	-0.02M		-0.08M	-0.01M		-0.06M	-0.04M		-0.13M				0.36M					-70.86M	-13.26M	2.40M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Repayments (Quarter)						15.00M		-14.81M		6.00M
Change in Capital Stock
Shares Issued (Quarter)	37.65M		-37.45M	37.45M				-14.81M		13.75M	-13.68M	-0.07M	108.10M	7.53M		67.60M		0.04M	-0.04M
Misc.
Cash from Financing Activities (Quarter)	37.83M	21.22M	47.64M	0.08M		-14.78M		0.08M	13.75M	0.60M	10.70M	0.00M	108.61M	-0.47M		67.71M		-0.47M	14.37M	0.69M
Change in Cash (Quarter)	19.49M	2.03M	31.27M	-17.03M	-16.07M	-27.31M	5.69M	-3.86M	3.56M	-10.43M	3.86M	-2.77M	102.77M	-16.75M	-11.53M	52.66M	-9.46M	-82.72M	-15.26M	-11.16M
Free Cash Flow (Quarter)	-18.34M	-19.19M	-16.37M	-17.11M	-16.07M	-12.47M	5.63M	-3.94M	-10.21M	-11.03M	-6.84M	-2.77M	-6.20M	-16.28M	-11.53M	-15.04M	-9.50M	-11.35M	-16.36M	-14.29M
Net Cash Flow (Quarter)	19.49M	2.03M	31.27M	-17.03M	-16.07M	-27.31M	5.69M	-3.86M	3.56M	-10.43M	3.86M	-2.77M	102.77M	-16.75M	-11.53M	52.66M	-9.50M	-82.68M	-15.26M	-11.20M

Research Tools

Avalo Therapeutics Cash Flow Statement (2014-2025) | AVTX

Create an account

Sign In

Reset Password